Analystreport

Krystal Biotech Inc (NASDAQ: KRYS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Krystal Biotech, Inc.  (KRYS) 
Last krystal biotech, inc. earnings: 11/4 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.krystalbio.com/investors